La UPV y Corify Care presentan la primera tecnología de mapeo de corazón completo que permite obtener una visión global de las arritmias cardiacas en un solo latido
Read moreOryzon Genomics has received a “Decision to grant” communication from the Japanese Patent Office for its patent application JP2023-136283, titled “Methods of treating behavior alterations”, re...
Read moreThe initiative proposes a patented system for encapsulating nucleic acids in solid silica nanoparticles that enables DNA preservation at room temperature. The project will be developed and validated i...
Read moreEsta tecnología permitirá la detección de infecciones potencialmente mortales y su resistencia a los antimicrobianos en menos de 30 minutos y a través de una pequeña muestra de sangre del pacient...
Read moreEl trabajo científico evalúa 12CLIP®, un dispositivo patentado que fue desarrollado para prevenir el contacto directo entre guantes no estériles y el conector del catéter. De esta forma ayuda a m...
Read morePharmacelera, a deep tech company applying Quantum Mechanics and Artificial Intelligence to revolutionize drug discovery based at the Barcelona Science Park (PCB-UB), has closed a €6 million investm...
Read moreOryzon Genomics today announced that the Mexican Patent Office has issued a decision to grant for its patent application MX/a/2021/011610, entitled “Combinations of iadademstat for cancer therapy”...
Read moreOryzon Genomics today announced that the United States Patent and Trademark Office has granted U.S. patent US12,564,559 B2, relating to therapeutic combinations of iadademstat, Oryzon’s potent and s...
Read morePowered by the Archer platform technology, IDT empowers molecular pathology laboratories with first in vitro diagnostic
Read moreCovers the use of vafidemstat for treating non-aggressive symptoms of Borderline Personality Disorder
Read moreGTX-11, developed by GAT Therapeutics and protected by patent, is a small oral molecule that modulates the TGFβ signalling pathway, a key factor in fibrotic processes, characterised by the excessive ...
Read moreCurapath has partnered with Nacalai Tesque to expand access to its portfolio of next-generation polymers and PEG-free shielding lipids for advanced drug delivery applications in Japan.
Read more